Prospectus

X4 Pharmaceuticals, Inc Filed 2025-09-18 Acc 0001501697-25-000024

Documents 1

2025-09-18 424B3 Prospectus
2025-09-17 EFFECT Notice of Effectiveness
2025-09-17 8-K Exit or restructuring costs · Executive or director change · Regulation FD disclosure
2025-09-15 CORRESP Correspondence Between Filers and SEC Staff
2025-09-15 SCHEDULE 13G Statement of Beneficial Ownership
2025-09-15 UPLOAD SEC-generated Letter
2023-06-21 424B3 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xforsept2025prosupp.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…